1 hour ago
1
alexsl
Novartis (NYSE:NVS) has been downgraded to Sell from Neutral at Goldman Sachs, citing concerns that recent share price outperformance and multiple expansion do not adequately reflect the risks facing the company.
"While the risks are not necessarily new, we believe that the
© FBT Company 2025. All rights are reserved
English (US) ·